Answers are grounded in this paper and cite their sources.
Albinism is a genetic disorder resulting in a lack of melanin. People with albinism (PWA) frequently experience discrimination and inadequate health care. Tanzania has a prevalence of albinism 30 times higher than the global average, with 1 in 1,400 persons affected. We sought to evaluate COVID-19 vaccine uptake, hesitancy, and barriers amongst this population through a mixed methods design. In Dar es Salaam and Mwanza, we conducted structured surveys and used conditional logistic regression to assess whether PWA had lower vaccine uptake compared to those without albinism. A total of 232 participants were included in the study. Across all study participants, PWA were less likely to be immunized for COVID-19 compared to their neighbor without albinism (Odds ratio 0.33, 95% confidence interval 0.14–0.81). Despite 44% of PWA expressing intent, only 14% received the COVID-19 vaccine. We found no significant differences surrounding intentions to receive childhood and future vaccines. In qualitative interviews, frequently cited barriers included inaccessible information, safety concerns, and discrimination. Despite similar intentions, PWA faced barriers that led to lower COVID-19 vaccination, suggesting that these disparities may be rooted in structural inequities. Targeted interventions to mitigate barriers must be implemented to prioritize this marginalized population.
No takes yet. Share an insight, caveat, or question.
Fazal et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: